South China Morning Post CENTER (0.0) Reliability: 7.5/10

Chinese drug makers strike a record US$136 billion in out-licensing deals in 2025

✍️ Julie Zhang 📅 January 08, 2026 12:30 AM ⏱️ 1 min read 🕐 Scraped: January 08, 2026

Summary: Chinese drug makers signed 157 out-licensing deals with global pharmaceutical firms last year versus 94 a year earlier.

Chinese drug makers’ licensing deals more than doubled in 2025 from a year earlier to a record high, propelled by dozens of multibillion-dollar agreements between Hong Kong and mainland China-listed

📰

Continue Reading on South China Morning Post

This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.

Read Full Article →

How do you feel about this article?

Read Original Article →

📝 Article Information

Author

Julie Zhang

Original Publisher

🌍 South China Morning Post

CENTER Bias (0.0)

Published Date

January 08, 2026 at 12:30 AM

ℹ️

Disclaimer

ArkforgeAI.com - Newsource is a news aggregation platform. We do not create, write, or produce original news content. All articles are sourced from their respective publishers and remain the property of their original creators. We analyze and aggregate news from multiple sources to provide diverse perspectives across the political spectrum.

The content displayed here is for informational purposes only. For the complete and original article, please visit the source's website using the "Read Original Article" link above.